Clinical trial
Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
NCT00307307 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00307307 |
|---|---|
| Title | Carotid Atherosclerosis Regression at Magnetic Resonance Assessment. |
| Official title | Magnetic Resonance Characterization of Carotid Atherosclerotic Plaque in Vivo: Effect of High Density Lipoprotein Elevation on Plaque Morphology |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | The Dana Foundation Merck Sharp & Dohme LLC Industry Kos Pharmaceuticals |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Established Carotid Atherosclerosis |
| Intervention type | Drug |
| Interventions | Niacin/simvastatin compared to simvastatin alone at 2 doses |
| Enrollment | 69 |
| Start date | Jan 1, 2000 |
| Completion | Sep 1, 2005 |
| First posted | Mar 27, 2006 |
| Last update posted | May 22, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: